Surgical Oncology is specialized training with a focus on the surgical management of cancers and other tumors. However, the practice of Surgical Oncology is more than just the practice of removing tumors.
Diseases of the liver and bile ducts are often complex and can lead to severe problems that can disrupt quality of life and can be life-threatening. Together, the liver and the biliary system represent some of the most complicated anatomy in the body.
The surgical management of pancreatic diseases is well known to be some of the most complicated operations requiring extensive training and experience. Pancreatic surgeons have received this training to thoroughly understand diseases of the pancreas.
…Thank you so much for the part you played in making the walk a success… We look forward to our future connection and hope to make it mutually beneficial so we can defeat this horrible disease. Thanks”
Thank you for your virtuoso hands, for your kind heart and talent. The best future is awaiting you in your practice…
Natalia and Larisa
About Dr. Mark Bloomston
Dr. Bloomston recently served as Associate Professor, Surgical Oncology Fellowship director, and director of the GI Cancer Service Line at Ohio State University. He has authored over 170 articles and served on the NCI Neuroendocrine task force and the NCCN Hepatobiliary guidelines committee. His interests are in complex GI cancers and advanced surgical procedures, such as complex pancreas surgery, major liver surgery, biliary reconstruction, hepatic artery infusion pumps, and isolated hepatic perfusion. He is ranked in the top 10 percentile for patient satisfaction and is considered one of the nation’s top doctors by US News and World Report.
We were proud to continue our support of the annual Lustgarten Foundation "Pancreatic Cancer Research Walk". Research remains our best strategy in fighting pancreatic cancer, and we are on the verge of incredible scientific breakthroughs. [...]
Most pancreatic cancers are exocrine cancers. Pancreatic neuroendocrine tumors (NETs), or islet cell tumors, are less common but tend to have a better outlook (prognosis). If you have pancreatic cancer or are close to someone [...]